Cabergoline (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Cabergoline drug offered from Mylan Pharmaceuticals Inc.. This Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | cabergoline |
| SUBSTANCE NAME: | CABERGOLINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-12-02 |
| END MARKETING DATE: | 0000-00-00 |
Cabergoline HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cabergoline from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/1) |
| START MARKETING DATE: | 2013-12-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-2800_e068ef51-a8cb-428a-9ab0-89d482ad7527 |
| PRODUCT NDC: | 0378-2800 |
| APPLICATION NUMBER: | ANDA202947 |
Other CABERGOLINE Pharmaceutical Manufacturers / Labelers:
